title: A comparison of pharmacological tobacco cessation relapse rates.
abstract: Tobacco use is the nation's leading preventable cause of chronic illness and injury; it takes the lives of 450,000 of our citizens each year. Currently, there are numerous treatment programs and pharmacological aids that may be obtained with a prescription or purchased over the counter at your local drugstore. The purpose of this study was to compare differences in tobacco cessation relapse rates of military personnel at the 1-, 3-, and 6-month intervals among 4 categories of pharmacological and cognitive regimens used at an outpatient naval treatment facility. A nonprobability convenience sampling plan was used to obtain (a) 10 patient-participant Freedom From Smoking (FFS) course records that utilized Zyban and Nicotine Replacement Therapy, (b) 10 patient-participant FFS course records that utilized Zyban only, (c) 10 patient-participant FFS course records that utilized Nicotine Replacement Therapy only, and (d) 10 patient-participant FFS course records that utilized Nicotine Replacement Therapy and nicotine gum (as needed). Findings revealed no significant difference between relapse and associated pharmacological treatment program. There was, however, a moderate increased cessation effort in Program 4 (nicotine replacement patch and nicotine gum). Results also demonstrated no significant difference between demographic variables and relapse cohorts. A significant positive relation between length of smoking and packs smoked per day was revealed, however.
authors.affiliation: Naval Medical Center, San Diego, CA 92106, USA. tmcmurry@cox.net
authors.forename: Timothy B
authors.initials: TB
authors.lastname: McMurry
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D000553:Ambulatory Care / Q000379:methods; D016642:Bupropion / Q000627:therapeutic use*; D002638:Chewing Gum; D003131:Combined Modality Therapy; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008145:Louisiana / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008889:Military Personnel / Q000706:statistics & numerical data; D009326:Naval Medicine / Q000379:methods; D009538:Nicotine / Q000627:therapeutic use*; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D010353:Patient Education as Topic / Q000379:methods*; D012008:Recurrence; D012189:Retrospective Studies; D012907:Smoking / Q000453:epidemiology; D016540:Smoking Cessation / Q000379:methods* / Q000706:statistics & numerical data; D000074606:Smoking Prevention; D016896:Treatment Outcome
chemical_list: D002638:Chewing Gum; D018765:Dopamine Uptake Inhibitors; D018722:Nicotinic Agonists; D016642:Bupropion; D009538:Nicotine